Literature DB >> 16006525

Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2.

Aimee L Eggler1, Guowen Liu, John M Pezzuto, Richard B van Breemen, Andrew D Mesecar.   

Abstract

The risks of cancer and other degenerative diseases caused by reactive oxygen species and electrophiles can be reduced by the up-regulation of detoxifying enzymes. A major mechanism whereby these protective enzymes are induced occurs through activation of the antioxidant response element (ARE) by the oxidative-stress sensor protein Kelch-like ECH-associated protein 1 (Keap1) and the transcription factor NF-E2-related factor 2 (Nrf2). Under basal conditions, Keap1 sequesters Nrf2 in the cytoplasm by binding to its Neh2 domain. Chemical inducers such as sulforaphane are known to react with Keap1 cysteine residues, thereby promoting Nrf2 nuclear accumulation and hence ARE activation. A widely accepted model for Nrf2 nuclear accumulation is that modification of Keap1 cysteines leads directly to dissociation of the Keap1-Nrf2 complex. This model is based on studies with mouse proteins and has served as the experimental basis and hypothesis for numerous investigations. Through a combination of chemical, mass spectrometry, and isothermal titration calorimetry methods, we have tested the direct-dissociation model using a series of ARE inducers: sulforaphane, isoliquiritigenin, 15-deoxy-Delta12,14-prostaglandin-J2, menadione, 1-Cl-2,4-dinitrobenzene, and biotinylated iodoacetamide. Surprisingly, these data suggest that the direct disruption model for Keap1-Nrf2 is incorrect. The relative reactivity of human Keap1 cysteines was determined. In addition to the same five cysteines identified for mouse Keap1, two highly reactive and previously unobserved cysteines were identified. Based on these results, a model is proposed that should aid in the understanding of Keap1-Nrf2 signaling mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16006525      PMCID: PMC1177374          DOI: 10.1073/pnas.0502402102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase.

Authors:  Sara B Cullinan; John D Gordan; Jianping Jin; J Wade Harper; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

Authors:  W H Habig; M J Pabst; W B Jakoby
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

Review 3.  Natural inhibitors of carcinogenesis.

Authors:  A Douglas Kinghorn; Bao-Ning Su; Dae Sik Jang; Leng Chee Chang; Dongho Lee; Jian-Qiao Gu; Esperanza J Carcache-Blanco; Alison D Pawlus; Sang Kook Lee; Eun Jung Park; Muriel Cuendet; Joell J Gills; Krishna Bhat; Hye-Sung Park; Eugenia Mata-Greenwood; Lynda L Song; Meishiang Jang; John M Pezzuto
Journal:  Planta Med       Date:  2004-08       Impact factor: 3.352

4.  Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.

Authors:  Nobunao Wakabayashi; Albena T Dinkova-Kostova; W David Holtzclaw; Moon-Il Kang; Akira Kobayashi; Masayuki Yamamoto; Thomas W Kensler; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

5.  Fetal Alz-50 clone 1 interacts with the human orthologue of the Kelch-like Ech-associated protein.

Authors:  Gordon D Strachan; Kathleen L Morgan; Linda L Otis; John Caltagarone; Aryn Gittis; Robert Bowser; Kelly L Jordan-Sciutto
Journal:  Biochemistry       Date:  2004-09-28       Impact factor: 3.162

6.  Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.

Authors:  Akira Kobayashi; Moon-Il Kang; Hiromi Okawa; Makiko Ohtsuji; Yukari Zenke; Tomoki Chiba; Kazuhiko Igarashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

7.  The potency of inducers of NAD(P)H:(quinone-acceptor) oxidoreductase parallels their efficiency as substrates for glutathione transferases. Structural and electronic correlations.

Authors:  S R Spencer; L A Xue; E M Klenz; P Talalay
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

8.  Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis.

Authors:  P Talalay; M J De Long; H J Prochaska
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products.

Authors:  Anna-Liisa Levonen; Aimee Landar; Anup Ramachandran; Erin K Ceaser; Dale A Dickinson; Giuseppe Zanoni; Jason D Morrow; Victor M Darley-Usmar
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

10.  NADPH oxidase and ERK signaling regulates hyperoxia-induced Nrf2-ARE transcriptional response in pulmonary epithelial cells.

Authors:  Srinivas Papaiahgari; Steven R Kleeberger; Hye-Youn Cho; Dhananjaya V Kalvakolanu; Sekhar P Reddy
Journal:  J Biol Chem       Date:  2004-07-29       Impact factor: 5.157

View more
  167 in total

1.  Screening for natural chemoprevention agents that modify human Keap1.

Authors:  Chenqi Hu; Dejan Nikolic; Aimee L Eggler; Andrew D Mesecar; Richard B van Breemen
Journal:  Anal Biochem       Date:  2011-10-22       Impact factor: 3.365

2.  Validation of the multiple sensor mechanism of the Keap1-Nrf2 system.

Authors:  Kai Takaya; Takafumi Suzuki; Hozumi Motohashi; Ko Onodera; Susumu Satomi; Thomas W Kensler; Masayuki Yamamoto
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

3.  INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.

Authors:  S K Niture; A K Jaiswal
Journal:  Cell Death Differ       Date:  2010-09-24       Impact factor: 15.828

4.  Proteomic analysis of covalent modifications of tubulins by isothiocyanates.

Authors:  Zhen Xiao; Lixin Mi; Fung-Lung Chung; Timothy D Veenstra
Journal:  J Nutr       Date:  2012-05-30       Impact factor: 4.798

5.  Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis.

Authors:  Suryakant K Niture; Anil K Jaiswal
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 6.  Detection of electrophile-sensitive proteins.

Authors:  Stephanie B Wall; M Ryan Smith; Karina Ricart; Fen Zhou; Praveen K Vayalil; Joo-Yeun Oh; Aimee Landar
Journal:  Biochim Biophys Acta       Date:  2013-09-08

7.  Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1.

Authors:  Takumi Satoh; Kunio Kosaka; Ken Itoh; Akira Kobayashi; Masayuki Yamamoto; Yosuke Shimojo; Chieko Kitajima; Jiankun Cui; Joshua Kamins; Shu-ichi Okamoto; Masanori Izumi; Takuji Shirasawa; Stuart A Lipton
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

8.  Quinone-induced activation of Keap1/Nrf2 signaling by aspirin prodrugs masquerading as nitric oxide.

Authors:  Tareisha Dunlap; Sujeewa C Piyankarage; Gihani T Wijewickrama; Samer Abdul-Hay; Michael Vanni; Vladislav Litosh; Jia Luo; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2012-10-18       Impact factor: 3.739

9.  Sites of alkylation of human Keap1 by natural chemoprevention agents.

Authors:  Yan Luo; Aimee L Eggler; Dongting Liu; Guowen Liu; Andrew D Mesecar; Richard B van Breemen
Journal:  J Am Soc Mass Spectrom       Date:  2007-10-02       Impact factor: 3.109

Review 10.  The cancer chemopreventive actions of phytochemicals derived from glucosinolates.

Authors:  John D Hayes; Michael O Kelleher; Ian M Eggleston
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.